Sandra Levy
ARTICLES BY THIS AUTHOR
- 3/15/2021
NACDS RxIMPACT announces Grassroots Awards during 2021 virtual program
Randy Edeker, president and CEO of Hy-Vee received the 2020 NACDS RxIMPACT Key Contact of the Year Award and Lynne Fruth, president of Fruth Pharmacy, won the award for 2021. - 3/15/2021
Strides Pharma obtains FDA green light for potassium chloride
Potassium chloride oral solution had a market value of $56 million, according to IQVIA January 2021 data. - 3/15/2021
APhA Foundation names 2021 Jacob W. Miller Award recipient
Susan WInckler, CEO of the Reagan-Udall Foundation for the FDA and a former FDA chief of staff, is the APhA Foundation's 2021 recipient of the Jacob W. Miller Award. - 3/15/2021
CVS Health offering COVID-19 antibody testing at all MinuteClinics in Massachusetts, Texas
COVID-19 antibody testing is available at nearly 60 MinuteClinic locations in Massachusetts and at more than 100 locations in Texas. - 3/15/2021
Cipla wins FDA OK for generic Imitrex
Imitrex Nasal Spray and its generic equivalents had a market value of approximately $53.3 million for the 12 months ended December 2020, according to IQVIA. - 3/15/2021
CVS Health’s transformation leader to take top job at Ontrak
Jonathan Maythew, is departing his role as CVS Health’s chief transformation officer to become CEO of virtual healthcare company Ontrak. - 3/15/2021
Zydus Cadila receives FDA nod for generic Pamelor
Zydus Cadila's generic Pamelor is indicated to treat such mental/mood problems as depression. - 3/15/2021
Lannett’s development of biosimilar Lantus advances with FDA feedback
Lannett expects to start a pivotal trial for its biosimilar Lantus early in 2022, with expectations of a launch in 2023. - 3/14/2021
Fresenius Kabi intros generic Foscavir
Fresenius Kabi is launching the first to market generic for Foscavir, a treatment for immune-compromised patients. - 3/14/2021
APhA, NASP call for comments on ‘Pharmacist’s Fundamental Responsibilities and Rights’
The American Pharmacists Association and the National Alliance of State Pharmacy Associations have released the “Pharmacist’s Fundamental Responsibilities and Rights” for public comment.
